Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

39,302 stories, page 326 of 656

Advanced search

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

SpaceMD's 2028 Starfall Mission Could Carry Up to 32 PIL-BOXes

Stock TitanOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

China is racing to cure cancer. America can’t afford to lose

Washington ExaminerOriginal source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

PacBio CEO steps down as Q2 loss widens

Fierce BiotechOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

S.D.-born biotech advances potential Type 1 diabetes therapy through global trial

SiouxFalls.BusinessOriginal source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

Braveheart pumps more life into biotech IPO market with $382M expected debut

BioSpaceOriginal source

🇺🇰Aug 6Regulatorygov.ukTier 1 · Regulatory source

Chlamydia Testing Activity Dataset (CTAD): specification and technical guidance

Guidance and specifications for the recording and extraction of CTAD data from laboratories in Engla...

UK Health Security AgencyOriginal source

🇺🇰Aug 6Regulatorygov.ukTier 1 · Regulatory source

Life Sciences Healthcare Goals

The Healthcare Goals programme brings together industry, academia, the third sector and the NHS to t...

UK Department of Health and Social CareOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

New manufacturing method will reduce centralised production

Scientist LiveOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

New kind of flu shot is on the way as FDA approves Moderna's mRNA-based vaccine

The Tribune-DemocratOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: Vivoryon narrows loss in H1 2026 as deal talks advance

Investing.comOriginal source

🇩🇪Aug 6Mediacharite.deTier 2 · Direct publisher

Enge digitale Begleitung hilft Frauen mit Brustkrebs

Charité - Universitätsmedizin Berlin (EN)Original source

🇩🇪Aug 6Researchcharite.deTier 2 · Direct publisher

Close digital support helps women with breast cancer

Charité - Universitätsmedizin Berlin (EN)Original source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

Two FDA approvals — a new drug and a new vaccine

STATOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Iraq wins legal case in Jordan for Samarra Pharmaceutical Company

Iraqi NewsOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels licence of Pune Ayurvedic medicine maker over safety violations

Mid-DayOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

FDA Approves Orzeyful, First Drug Targeting Underlying Cause of Narcolepsy

drugtopics.comOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

FDA Okays First-in-Class Narcolepsy Drug Oveporexton

MedscapeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

FDA Approves the First mRNA Flu Vaccine

Time MagazineOriginal source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

BioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program

Fierce BiotechOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Private Philanthropy: We Need Ethics to Match It — Ethicist

MedscapeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Why is Collegium Pharmaceutical stock tumbling today? By Investing.com

Investing.com CanadaOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Reckitt obtains FDA nod for new OTC cold and flu medication

Drug Store NewsOriginal source

🇮🇹Aug 6Researchhumanitas.itTier 2 · Direct publisher

Salgono a due le sedi IRCCS di Humanitas

Humanitas Research HospitalOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

FDA Approves Moderna's mRNA-Based Flu Vaccine

Pharmaceutical ExecutiveOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

FAQ: Inside Pharma’s Changing Hub Landscape

Pharmaceutical CommerceOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical falls 13% on weak revenue guidance By Investing.com

Investing.com South AfricaOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical Q2 Earnings Call Highlights

Yahoo FinanceOriginal source

🇺🇸Aug 6CROmedidata.comTier 2 · Direct publisher

Is AI Actually Improving the Patient Experience?

Medidata SolutionsOriginal source

🇺🇰Aug 6Regulatorygov.ukTier 1 · Regulatory source

Measles: Historic confirmed cases, notifications and deaths

Laboratory-confirmed cases and notifications of measles in England. Deaths apply to England and Wale...

UK Health Security AgencyOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

This drug researcher just reported earnings and could keep rallying on biotech bounceback, JPMorgan says

CNBCOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

FDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients

Medical DailyOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

StockStoryOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

breitbart.comOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

BioVie reports positive phase 2 Parkinson's results, eyes pivotal Phase 3 trial

Proactive InvestorsOriginal source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

A scientist-turned-biotech executive is notching some wins, and enjoying it

STATOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

User

The Chronicle-JournalOriginal source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui

Fierce BiotechOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

The Manila TimesOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

The Manila TimesOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Retatrutide Will Not Reach the FDA Until Early 2027, Leaving No Price and No Coverage Decision to Point To

inklOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Republican U.S. Senator Rick Scott Joins Democrat U.S. Senator Kirsten Gillibrand Pressing President Trump’s FDA On Shortage Of Cancer Drugs

Sierra Sun TimesOriginal source

🇯🇵Aug 6Industrynippon-shinyaku.co.jpTier 1 · Company source

2027年3月期第1四半期決算発表

Nippon Shinyaku NewsOriginal source

🇨🇦Aug 6Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

One lot of New Roots Herbal Probiotic Intensity recalled due to incorrect “No Dairy” claim

New Roots Herbal Inc. is recalling one lot of Probiotic Intensity because the outer box of the 30-co...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 6Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

HEALON EndoCoat PRO

Johnson & Johnson Surgical Vision, Inc. is issuing a voluntary recall notice for HEALON EndoCoat™ PR...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 6Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Beckman Coulter AU Immunochemistry System - AU480 Analyzer

Beckman Coulter has determined that a software defect in AU480 chemistry analyzers using Microsoft®...

Health Canada Recalls and Safety AlertsOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Theriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing

Stock TitanOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Edgewise Therapeutics Reports Second Quarter 2026 Financial Results

tradingview.comOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Theriva™ Biologics Announces First Patient Dosed in VIRAGE2

GlobeNewswireOriginal source

🌍Aug 6Industryinvestors.vivani.comTier 1 · Company source

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Vivani MedicalOriginal source

🌍Aug 6discoverynews.google.comTier 2 · Trade media

Takeda's first-in-class narcolepsy drug claims FDA approval

pharmaphorumOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Amgen Ecovation®: How Amgen Builds Sustainability Into Biotech

AmgenOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

BioVie reports positive phase 2 Parkinson's results, eyes pivotal Phase 3 trial

Proactive financial newsOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Lexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission

Quiver QuantitativeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

BioVie reports positive phase 2 Parkinson's results, eyes pivotal Phase 3 trial

Proactive financial newsOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE) and Allogene Therapeutics (ALLO)

The Globe and MailOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Avalo Therapeutics Announces Plans for Phase 3 Abdakibart HS Program, Advancement of AVTX-010 and Second Quarter 2026 Financial Results

Quiver QuantitativeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Intellia Therapeutics Reports Positive Phase 3 HAELO Data for Lonvo-z, Advances Nex-z Trials and Reaffirms Cash Runway Into 2028

Quiver QuantitativeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Cartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership

Quiver QuantitativeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Ocugen Reports Q2 2026 Results, Advances OCU410 Phase 3, Secures RMAT Designation and $130 Million Financing

Quiver QuantitativeOriginal source

🌍Aug 6discoverynews.google.comTier 3 · Aggregated media

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Intellia TherapeuticsOriginal source